Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis ; volume:17 ; number:1 ; day:10 ; month:12 ; year:2019 ; pages:1-15 ; date:12.2019
BMC medicine ; 17, Heft 1 (10.12.2019), 1-15, 12.2019
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12916-019-1457-8
- URN
-
urn:nbn:de:101:1-2020032419383278362019
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Momtazi-Borojeni, Amir Abbas
- Jaafari, Mahmoud Reza
- Badiee, Ali
- Banach, Maciej
- Sahebkar, Amirhossein
- SpringerLink (Online service)
Ähnliche Objekte (12)
Retraction Note: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
Effects of PCSK9 Targeting : Alleviating Oxidation, Inflammation, and Atherosclerosis
PCSK9 concentrations in different stages of subclinical atherosclerosis and their relationship with inflammation
Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease
Exploring potential novel therapeutic targets for atherosclerosis and atherosclerosis-related pathologies
PCSK9 stimulates Syk, PKCδ, and NF-κB, leading to atherosclerosis progression independently of LDL receptor
Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina
Gene Therapy Targeting PCSK9
Research progress on alternative non-classical mechanisms of PCSK9 in atherosclerosis in patients with and without diabetes
Noncoding RNAs in atherosclerosis: regulation and therapeutic potential
Interleukin-22: a potential therapeutic target in atherosclerosis
Perspectives for therapeutic HPV vaccine development
Retraction Note: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
Effects of PCSK9 Targeting : Alleviating Oxidation, Inflammation, and Atherosclerosis
PCSK9 concentrations in different stages of subclinical atherosclerosis and their relationship with inflammation
Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease
Exploring potential novel therapeutic targets for atherosclerosis and atherosclerosis-related pathologies
PCSK9 stimulates Syk, PKCδ, and NF-κB, leading to atherosclerosis progression independently of LDL receptor
Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina
Gene Therapy Targeting PCSK9
Research progress on alternative non-classical mechanisms of PCSK9 in atherosclerosis in patients with and without diabetes
Noncoding RNAs in atherosclerosis: regulation and therapeutic potential
Interleukin-22: a potential therapeutic target in atherosclerosis
Perspectives for therapeutic HPV vaccine development
Retraction Note: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
Effects of PCSK9 Targeting : Alleviating Oxidation, Inflammation, and Atherosclerosis
PCSK9 concentrations in different stages of subclinical atherosclerosis and their relationship with inflammation
Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease
Exploring potential novel therapeutic targets for atherosclerosis and atherosclerosis-related pathologies
PCSK9 stimulates Syk, PKCδ, and NF-κB, leading to atherosclerosis progression independently of LDL receptor
Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina
Gene Therapy Targeting PCSK9
Research progress on alternative non-classical mechanisms of PCSK9 in atherosclerosis in patients with and without diabetes
Noncoding RNAs in atherosclerosis: regulation and therapeutic potential
Interleukin-22: a potential therapeutic target in atherosclerosis